531 related articles for article (PubMed ID: 6285085)
21. Calmodulin regulation of testicular cyclic nucleotide phosphodiesterases.
Purvis K; Hansson V
Int J Androl; 1980 Dec; 3(6):713-8. PubMed ID: 6259062
[TBL] [Abstract][Full Text] [Related]
22. Purification and characterization of a cyclic GMP-stimulated cyclic nucleotide phosphodiesterase from the cytosol of human platelets.
Grant PG; Mannarino AF; Colman RW
Thromb Res; 1990 Jul; 59(1):105-19. PubMed ID: 2169075
[TBL] [Abstract][Full Text] [Related]
23. Modulation of rat thymocyte proliferative response through the inhibition of different cyclic nucleotide phosphodiesterase isoforms by means of selective inhibitors and cGMP-elevating agents.
Marcoz P; Prigent AF; Lagarde M; Nemoz G
Mol Pharmacol; 1993 Nov; 44(5):1027-35. PubMed ID: 8246905
[TBL] [Abstract][Full Text] [Related]
24. [3',5'-cyclic nucleotide phosphodiesterase from human brain].
Bobruskin ID; Muratova MV; Kireeva NN; Belov AA; Severin ES
Biokhimiia; 1989 Sep; 54(9):1499-507. PubMed ID: 2556185
[TBL] [Abstract][Full Text] [Related]
25. Inhibitory effect of regucalcin on Ca2+/calmodulin-dependent cyclic AMP phosphodiesterase activity in rat kidney cytosol.
Yamaguchi M; Kurota H
Mol Cell Biochem; 1997 Dec; 177(1-2):209-14. PubMed ID: 9450664
[TBL] [Abstract][Full Text] [Related]
26. 7-Bromo-1,5-dihydro-3,6-dimethylimidazo[2,1-b]quinazolin-2(3H)- one (Ro 15-2041), a potent antithrombotic agent that selectively inhibits platelet cyclic AMP-phosphodiesterase.
Muggli R; Tschopp TB; Mittelholzer E; Baumgartner HR
J Pharmacol Exp Ther; 1985 Oct; 235(1):212-9. PubMed ID: 2995647
[TBL] [Abstract][Full Text] [Related]
27. Chromatographic behavior of cyclic 3',5'-nucleotide phosphodiesterases on columns of immobilized inhibitors.
Mohindru A; Chenet A; Rhoads AR
Biochemistry; 1978 Aug; 17(16):3297-304. PubMed ID: 80229
[No Abstract] [Full Text] [Related]
28. Inhibitory effects of flavonoids on phosphodiesterase isozymes from guinea pig and their structure-activity relationships.
Ko WC; Shih CM; Lai YH; Chen JH; Huang HL
Biochem Pharmacol; 2004 Nov; 68(10):2087-94. PubMed ID: 15476679
[TBL] [Abstract][Full Text] [Related]
29. The identification and characterization of two cyclic nucleotide phosphodiesterases from bovine adrenal medulla.
Sabatine JM; Coffee CJ
Arch Biochem Biophys; 1986 Aug; 249(1):95-105. PubMed ID: 3017224
[TBL] [Abstract][Full Text] [Related]
30. Effects of cyclic AMP- and cyclic GMP- phosphodiesterase inhibitors on immunological release of histamine and on lung contraction.
Frossard N; Landry Y; Pauli G; Ruckstuhl M
Br J Pharmacol; 1981 Aug; 73(4):933-8. PubMed ID: 6168323
[TBL] [Abstract][Full Text] [Related]
31. [Cyclic AMP-specific nucleotide phosphodiesterase from the insoluble fraction of the human brain].
Kireeva NN; Bobruskin ID; Severin SE
Biokhimiia; 1995 May; 60(5):694-708. PubMed ID: 7662796
[TBL] [Abstract][Full Text] [Related]
32. Purification and characterization of calmodulin-dependent functional protein, phosphodiesterase, in the lens.
Yamamoto T; Iwata S
Jpn J Ophthalmol; 1987; 31(4):570-81. PubMed ID: 2834593
[TBL] [Abstract][Full Text] [Related]
33. Cyclic nucleotide phosphodiesterase from rat small intestine: the separation of the cyclic GMP and cyclic AMP phosphodiesterases.
Yamamoto S
Bull Osaka Med Sch; 1977 Oct; 23(2):92-106. PubMed ID: 210871
[No Abstract] [Full Text] [Related]
34. Papaverine and Ro 20-1724 inhibit cyclic nucleotide phosphodiesterase activity and increase cyclic AMP levels in psoriatic epidermis in vitro.
Rusin LJ; Duell EA; Voorhees JJ
J Invest Dermatol; 1978 Aug; 71(2):154-6. PubMed ID: 210235
[TBL] [Abstract][Full Text] [Related]
35. A comparative kinetic study of bovine calmodulin-dependent cyclic nucleotide phosphodiesterase isozymes utilizing cAMP, cGMP and their 2'-O-anthraniloyl-,2'-O-(N-methylanthraniloyl)-derivatives as substrates.
Grewal J; Karuppiah N; Mutus B
Biochem Int; 1989 Dec; 19(6):1287-95. PubMed ID: 2561449
[TBL] [Abstract][Full Text] [Related]
36. Inhibition of calmodulin-activated cyclic nucleotide phosphodiesterase: multiple binding-sites for tricyclic drugs on calmodulin.
Reynolds CH; Claxton PT
Biochem Pharmacol; 1982 Feb; 31(3):419-21. PubMed ID: 6280730
[TBL] [Abstract][Full Text] [Related]
37. Studies on the soluble phosphodiesterases of chicken gizzard smooth muscle.
Birnbaum RJ; Head JF
Biochem J; 1983 Dec; 215(3):627-36. PubMed ID: 6318728
[TBL] [Abstract][Full Text] [Related]
38. 1-(4-Aminophenyl)isoquinoline derivatives. Potent inhibitors of calcium-independent and calcium-dependent phosphodiesterases from rat cerebral cortex.
Davis CW; Walker KA
Biochem Pharmacol; 1984 Apr; 33(8):1205-12. PubMed ID: 6324818
[TBL] [Abstract][Full Text] [Related]
39. Characterization of the soluble cyclic nucleotide phosphodiesterases in Xenopus laevis oocytes. Evidence for a calmodulin-dependent enzyme.
Miot F; Erneux C
Biochim Biophys Acta; 1982 Feb; 701(2):253-9. PubMed ID: 6280770
[TBL] [Abstract][Full Text] [Related]
40. Inhibition of bovine brain cyclic nucleotide phosphodiesterase by a proteinaceous factor from Escherichia coli.
Iwasa Y
Horm Metab Res; 1982 May; 14(5):265-7. PubMed ID: 6284629
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]